GE HealthCare Technologies Inc. Leases Disclosure
Operating Lease Assets and Liabilities | As of | |||||||
| December 31, 2025 | December 31, 2024 | |||||||
| Operating lease ROU assets | $ | 410 | $ | 364 | ||||
| Current operating lease liabilities | 134 | 115 | ||||||
| Non-current operating lease liabilities | 284 | 270 | ||||||
| Total operating lease liabilities | $ | 419 | $ | 385 | ||||
Operating Lease Expense | For the years ended December 31 | ||||||||||
| 2025 | 2024 | 2023 | |||||||||
| Long-term (fixed) | $ | 136 | $ | 134 | $ | 121 | |||||
| Long-term (variable) | 101 | 120 | 106 | ||||||||
| Short-term | 12 | 4 | 2 | ||||||||
| Total operating lease expense | $ | 249 | $ | 258 | $ | 229 | |||||
| Maturity of Lease Liabilities | |||||||||||||||||||||||
| 2026 | 2027 | 2028 | 2029 | 2030 | Thereafter | Total | |||||||||||||||||
| Undiscounted lease payments | $ | 153 | $ | 116 | $ | 73 | $ | 42 | $ | 20 | $ | 56 | $ | 460 | |||||||||
| Less: imputed interest | 41 | ||||||||||||||||||||||
Total lease liability as of December 31, 2025 | $ | 419 | |||||||||||||||||||||
Supplemental Information Related to Operating Leases | For the years ended December 31 | ||||||||||
| 2025 | 2024 | 2023 | |||||||||
Cash paid for amounts included in the measurement of operating lease liabilities | $ | 151 | $ | 138 | $ | 130 | |||||
| Right-of-use assets obtained in exchange for new lease liabilities | 162 | 147 | 154 | ||||||||
| Weighted-average remaining lease term (in years) | 4.6 | 4.4 | 4.7 | ||||||||
| Weighted-average discount rate | 4.4 | % | 4.5 | % | 4.4 | % | |||||
Net Investment in Finance Leases | As of | |||||||
| December 31, 2025 | December 31, 2024 | |||||||
Minimum lease payments receivable | $ | 243 | $ | 242 | ||||
| Less: deferred income | (30) | (31) | ||||||
| Discounted lease receivable | 213 | 211 | ||||||
| Estimated unguaranteed residual value of leased assets, net of deferred income | 12 | 10 | ||||||
Investment in finance leases, net of deferred income | $ | 225 | $ | 221 | ||||
| Contractual Maturities | |||||||||||||||||||||||
| Due In | 2026 | 2027 | 2028 | 2029 | 2030 | Thereafter | Total | ||||||||||||||||
Minimum lease payments receivable | $ | 86 | $ | 56 | $ | 39 | $ | 26 | $ | 16 | $ | 19 | $ | 243 | |||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 4, 2026 | Showing above |
| 2024 | Feb 13, 2025 | |
| 2023 | Feb 6, 2024 | |
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.